NCT00468845

Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy

A Multiple Dose, Randomized, Double-Blind Multicenter Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo In The Treatment Of Patients With Post-Surgical Pain From Hysterectomy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 501 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: Female
• Age: 25 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To assess the efficacy of pregabalin compared to placebo on pain following hysterectomy , measured using subject reported assessments of pain.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	pregabalin (Lyrica)	150 mg/day double blind (divided doses)
DRUG	pregabalin (Lyrica)	300 mg/day double blind (divided doses)
DRUG	matched placebo	matched placebo

Timeline

• Start date: 2007-06-01
• Primary completion: 2010-05-01
• Completion: 2010-10-01
• First posted: 2007-05-03
• Last updated: 2021-02-10
• Results posted: 2011-05-26

Locations

42 sites across 9 countries: United States, Canada, Czechia, Hong Kong, South Africa, Spain, Sweden, Thailand, United Kingdom